Edition:
United States

Kitov Pharmaceuticals Holdings Ltd (KTOV.OQ)

KTOV.OQ on NASDAQ Stock Exchange Capital Market

2.05USD
13 Dec 2017
Change (% chg)

$0.02 (+0.99%)
Prev Close
$2.03
Open
$2.03
Day's High
$2.08
Day's Low
$2.01
Volume
18,309
Avg. Vol
67,589
52-wk High
$3.49
52-wk Low
$1.27

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

John Waymack

63 2013 Chairman of the Board & Chief Medical Officer

Itzhak Israel

37 2012 Chief Executive Officer, Director

Simcha Rock

65 2013 Chief Financial Officer, Director

Gil Ben-Menachem

2016 Vice President - Business Development

Yisrael Gewirtz

40 2016 Internal Auditor